Partner

Unit 2901, 29 F, Tower C
Beijing Yintai Centre, No. 2 Jianguomenwai Avenue, Chaoyang District
Beijing

+86 10 65298308

Highly regarded

Chinese and English


Jurisdictions:

China

Practice areas:

Capital markets : Equity


Dan Ouyang is a partner in the Beijing and Hong Kong offices of Wilson Sonsini Goodrich & Rosati, where she leads the capital market practice in the Greater China group. Dan has extensive experience with U.S. and Hong Kong equity offerings, Rule 144A and Reg S bond offerings, and private equity and M&A transactions. She has represented corporate clients across a range of industries, including technology, healthcare, and entertainment, in more than 100 IPOs and follow-on offerings in the U.S. and Hong Kong.
Dan started her legal career in New York, and prior to joining the firm, Dan was a partner at a large international firm’s Beijing office. She was also previously a journalist at China Central Television and China Radio International.
Dan is a native speaker of Mandarin Chinese and is fluent in English.

Hong Kong Capital Markets
Equity Experience

  • Represented sole sponsor in EDIANYUN Limited’s US$76 million Hong Kong IPO and listing
    Represented issuer in Beijing Luzhu Biotechnology Co., Ltd.’s US$43.4 million Hong Kong IPO and listing
  • Represented issuer in Fenbi Ltd.’s US$25.5 million Hong Kong IPO and listing
  • Represented issuer in TechStar Acquisition Corporation’s Hong Kong listing
  • Represented issuer in Newlink Technology Inc.’s HK$872 million Hong Kong IPO and listing
  • Represented issuer in Zero2IPO Holdings Inc.’s HK$506 million Hong Kong IPO and listing
  • Represented underwriters in Shandong Fengxiang Co., Ltd.’s HK$1.182 billion global offering and IPO
  • Represented underwriters in Zhenro Services Group Limited’s HK$1.07 billion global offering and IPO

U.S. Capital Markets

  • Represented YS Bio in its de-SPAC listing on NYSE
  • Represented the issuer in QuantaSing Group Limited's Nasdaq IPO
  • Represented the issuer in Cloopen Group Holding Limited’s US$368 million global offering and initial public offering

 

  • Corporate Finance
  • Merger & Acquisitions
  • Corporate Law & Governance
  • Greater China and Private Equity

  • New York
  • Hong Kong

  • J.D., Cornell Law School
  • M.A., Cornell University
  • B.A., Peking University